Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar F F, Bartsch H, Malaveille C, Vineis P
Institute for Environmental Health, University of Cincinnati, Ohio 45267-0056.
Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):61-6.
The presence of covalent modifications in DNA obtained from exfoliated urothelial cells of smokers and nonsmokers was determined using 32P postlabeling methods. Urine and blood samples were procured from 73 persons. Cells were removed from the urine by filtration. DNA was isolated using an enzyme-solvent extraction method and then coprecipitated with glycogen. Sufficient DNA to detect 1 carcinogen-DNA adduct/10(9) normal nucleotides was obtained from 40 of the 73 samples. DNA was hydrolyzed to 3'-phosphodeoxynucleotides and then 32P postlabeled under conditions of excess [32P]ATP. Carcinogen-DNA adducts were resolved using anion-exchange thin-layer chromatography and visualized by autoradiography; film exposures lasted as long as 7 days. Twelve different carcinogen-DNA adducts and a diagonal zone of radioactivity could be found, but no sample contained all adducts. At least four adducts appeared to be cigarette smoking related. These adducts were from 2 to 20 times higher in the smokers than the nonsmokers. Two carcinogen-DNA adducts were qualitatively very similar to adducts described earlier in a study of human bladder biopsies. One of these corresponded to N-(deoxyguanosin-8-yl)-4-aminobiphenyl. Adducts were correlated significantly with the levels of 4-aminobiphenyl hemoglobin adducts and number of cigarettes smoked. In addition, levels of the putative N-(deoxyguanosin-8-yl)-4-aminobiphenyl adduct and a measure of total adducts were correlated with the mutagenic activity of the individual's urine. These data suggest that noninvasive, biological monitoring techniques can be applied to the study of carcinogen-DNA adducts in humans at high risk for bladder cancer.
采用³²P后标记法测定吸烟者和非吸烟者脱落尿路上皮细胞DNA中是否存在共价修饰。从73人采集尿液和血液样本。通过过滤从尿液中分离细胞。使用酶 - 溶剂萃取法分离DNA,然后与糖原共沉淀。73个样本中的40个获得了足以检测到1个致癌物 - DNA加合物/10⁹个正常核苷酸的DNA量。DNA被水解为3'-磷酸脱氧核苷酸,然后在过量[³²P]ATP条件下进行³²P后标记。致癌物 - DNA加合物通过阴离子交换薄层色谱法分离,并用放射自显影法可视化;胶片曝光长达7天。可以发现12种不同的致癌物 - DNA加合物和一个放射性对角线区域,但没有一个样本包含所有加合物。至少有四种加合物似乎与吸烟有关。这些加合物在吸烟者中的含量比非吸烟者高2至20倍。两种致癌物 - DNA加合物在质量上与先前在一项人类膀胱活检研究中描述的加合物非常相似。其中一种对应于N - (脱氧鸟苷 - 8 - 基) - 4 - 氨基联苯。加合物与4 - 氨基联苯血红蛋白加合物水平和吸烟支数显著相关。此外,推定的N - (脱氧鸟苷 - 8 - 基) - 4 - 氨基联苯加合物水平和总加合物的测量值与个体尿液的诱变活性相关。这些数据表明,非侵入性生物监测技术可应用于膀胱癌高危人群中致癌物 - DNA加合物的研究。